Psychiatric diagnosis in patients with systemic lupus erythematosus (SLE) is controversial: variations have been reported in frequency, diagnostic assays, associations with disease activity, autoantibodies, and contributing social factors. Eighty-three consecutive non-selected Chilean patients with SLE were evaluated for: (i) 26 common mental disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), using the Mini-International Neuropsychiatric Interview (MINI-plus); (ii) psychological suffering measured by Hospital Anxiety and Depression Scale (HADS); (iii) ACR 1999 neuropsychiatric (NP)SLE criteria; (iv) SLE disease activity (SLEDAI-2K); (v) cumulative damage (SLICC/ACR); and (vi) anti-ribosomal P antibodies by enzyme-linked immunoassay and immunoblot. Psychiatric diagnoses occurred in 44.6% of patients; the most frequent (21.7%) was major depressive episode (MDE). No association with lupus activity was observed in patients with a DSM-IV diagnosis or MDE or psychological suffering. ACR 1999 NPSLE criteria were present in 42.2% of patients, the majority corresponding to mood (28.9%) or anxiety disorders (15.6%). Suicidal risk was present in 9.6% of patients. Anti-ribosomal P antibodies (13.3%) were not associated with DSM-IV diagnosis. Severe psychiatric disorders in SLE are common and not associated with disease activity.
DeGiorgioLAKonstantinovKNLeeSCHardinJAVolpeBTDiamondB. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med2001; 7: 1189–1193.
2.
HuertaPTKowalCDeGiorgioLAVolpeBTDiamondB. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A2006; 103: 678–683.
3.
MatusSBurgosPVBravo-ZehnderM. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med2007; 204: 3221–3234.
4.
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599–608.
5.
MokCCLauCSWongRW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol2001; 28: 766–771.
6.
AinialaHHietaharjuALoukkolaJ. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum2001; 45: 419–423.
7.
HanlyJG. Neuropsychiatric lupus. Rheum Dis Clin North Am2005; 31: 273–298, vi.
HanlyJGMcCurdyGFougereLDouglasJAThompsonK. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol2004; 31: 2156–2162.
10.
HayEMBlackDHuddyA. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum1992; 35: 411–416.
11.
NeryFGBorbaEFHatchJPSoaresJCBonfaENetoFL. Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry2007; 48: 14–19.
12.
MiguelECPereiraRMPereiraCA. Psychiatric manifestations of systemic lupus erythematosus: clinical features, symptoms, and signs of central nervous system activity in 43 patients. Medicine (Baltimore)1994; 73: 224–232.
13.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 2004.
14.
Pons-EstelBACatoggioLJCardielMH. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”. Medicine (Baltimore)2004; 83: 1–17.
15.
SheehanDVLecrubierYSheehanKH. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry1998; 59(Suppl 20): 22–33;quiz 34–57.
16.
KarassaFBAfeltraAAmbrozicA. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum2006; 54: 312–324.
GladmanDDGoldsmithCHUrowitzMB. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol2000; 27: 373–376.
20.
WeeningJJD’AgatiVDSchwartzMM. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol2004; 15: 241–250.
21.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
22.
FolsteinMFFolsteinSEMcHughPR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–198.
23.
LoboASazPMarcosG. [Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population]. Med Clin (Barc)1999; 112: 767–774.
24.
InouyeSKvan DyckCHAlessiCABalkinSSiegalAPHorwitzRI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med1990; 113: 941–948.
25.
ZigmondASSnaithRP. The hospital anxiety and depression scale. Acta Psychiatr Scand1983; 67: 361–370.
26.
MassardoLBurgosPMartinezME. Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease. Lupus2002; 11: 379–383.
27.
LewisGPelosiAJArayaRDunnG. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med1992; 22: 465–486.
28.
ArayaRRojasGFritschRAcunaJLewisG. Common mental disorders in Santiago, Chile: prevalence and socio-demographic correlates. Br J Psychiatry2001; 178: 228–233.
29.
VicenteBKohnRRiosecoPSaldiviaSLevavITorresS. Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study. Am J Psychiatry2006; 163: 1362–1370.
30.
WeissmanMMLeafPJTischlerGL. Affective disorders in five United States communities. Psychol Med1988; 18: 141–153.
31.
HanlyJGKutznetsovaAFiskJD. Psychopathology of Lupus and Neuroimaging. In: WallaceDJHahnBH (eds), Dubois’ Lupus Erythematosus. Vol 1, Philadelphia: Lippincott Williams & Wilkins; 2007. 747–774.
32.
DrussBPincusH. Suicidal ideation and suicide attempts in general medical illnesses. Arch Intern Med2000; 160: 1522–1526.
33.
BreyRLHollidaySLSakladAR. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology2002; 58: 1214–1220.
34.
SibbittWLJrBrandtJRJohnsonCR. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol2002; 29: 1536–1542.
35.
HanlyJGUrowitzMBSuL. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis2010; 69: 529–535.
36.
MassardoLMartinezMEJacobelliSVillarroelLRosenbergHRiveroS. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum1994; 24: 1–11.
37.
Alarcon-SegoviaDAlarcon-RiquelmeMECardielMH. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum2005; 52: 1138–1147.
38.
MontgomerySAAsbergM. A new depression scale designed to be sensitive to change. Br J Psychiatry1979; 134: 382–389.
39.
PolskyDDoshiJAMarcusS. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med2005; 165: 1260–1266.
40.
ShortallEIsenbergDNewmanSP. Factors associated with mood and mood disorders in SLE. Lupus1995; 4: 272–279.
41.
HanlyJGFiskJDMcCurdyGFougereLDouglasJA. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol2005; 32: 1459–1456.
42.
DickensCJacksonJTomensonBHayECreedF. Association of depression and rheumatoid arthritis. Psychosomatics2003; 44: 209–215.
43.
NgTPNitiMTanWCCaoZOngKCEngP. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med2007; 167: 60–67.
44.
WekkingEM. Psychiatric symptoms in systemic lupus erythematosus: an update. Psychosom Med1993; 55: 219–228.
45.
HugoFJHallandAMSpangenbergJJ. DSM-III-R classification of psychiatric symptoms in systemic lupus erythematosus. Psychosomatics1996; 37: 262–269.
46.
HarrisonMJRavdinLDLockshinMD. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum2006; 54: 2515–2522.
47.
BonfaEGolombekSJKaufmanLD. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med1987; 317: 265–271.
48.
SchneebaumABSingletonJDWestSG. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med1991; 90: 54–62.
49.
BrianiCLucchettaMGhirardelloA. Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun2009; 32: 79–84.
50.
GhirardelloABrianiCLucchettaMDoriaA. Anti-ribosomal P protein antibodies and neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies. Lupus2010; 19: 771–773.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
